Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov

Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brazilian journal of microbiology 2015-07, Vol.46 (3), p.861-865
Hauptverfasser: Visnuvinayagam, Sivam, Thangavel, K, Lalitha, N, Malmarugan, S, Sukumar, Kuppannan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 865
container_issue 3
container_start_page 861
container_title Brazilian journal of microbiology
container_volume 46
creator Visnuvinayagam, Sivam
Thangavel, K
Lalitha, N
Malmarugan, S
Sukumar, Kuppannan
description Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.
doi_str_mv 10.1590/S1517-838246320140051
format Article
fullrecord <record><control><sourceid>proquest_sciel</sourceid><recordid>TN_cdi_scielo_journals_S1517_83822015000300861</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S1517_83822015000300861</scielo_id><sourcerecordid>1717482833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-7997ed1f6944bd80dd6243f78ebe6c5b15ea0e6b723df3765854a59075a2064d3</originalsourceid><addsrcrecordid>eNpdUctu1DAUtRCIlsIngCKxYZNy_XY2SFUFBVHBAthiOfFNx1UmHmxnUP--HqaMBla27HPuPQ9CXlI4p7KDt9-opLo13DChOAMqACR9RE6p0qYVAuTjo_sJeZbzLQCTINhTcsKUoBw0PSU_L3LGnNc4lyaOTVlhs3FlFW9wDkMod7vHAaepHZapLAlb592moG--4O_B5TJh40NGl7HZhrTkJpfkwtx8jmuX4vY5eTK6KeOLh_OM_Pjw_vvlx_b669Wny4vrdhDalFZ3nUZPR9UJ0XsD3ism-KgN9qgG2VOJDlD1mnE_cq2kkcLVFLR0DJTw_Iyc7-fmIeAU7W1c0lwX2j8x2V1MNSMJABzAKFoJ7_aEzdKv0Q_Vf3KT3aRQdd_Z6IL992cOK3sTt1ZIZfYD3jwMSPHXgrnYdci7pNyMccmWaqqFYYbzCn39H_Qgj2pQVEvDuoqSe9SQYs4Jx4MYCnZX-ZGXo8or79WxkwPrb8f8Hm7xpXU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706175829</pqid></control><display><type>article</type><title>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Visnuvinayagam, Sivam ; Thangavel, K ; Lalitha, N ; Malmarugan, S ; Sukumar, Kuppannan</creator><creatorcontrib>Visnuvinayagam, Sivam ; Thangavel, K ; Lalitha, N ; Malmarugan, S ; Sukumar, Kuppannan</creatorcontrib><description>Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.</description><identifier>ISSN: 1678-4405</identifier><identifier>ISSN: 1517-8382</identifier><identifier>EISSN: 1678-4405</identifier><identifier>DOI: 10.1590/S1517-838246320140051</identifier><identifier>PMID: 26413071</identifier><language>eng</language><publisher>Brazil: Springer Nature B.V</publisher><subject>Animal diseases ; Animals ; Cell Culture Techniques ; Cells, Cultured ; Chick Embryo ; Chickens - immunology ; Chickens - virology ; MICROBIOLOGY ; Newcastle disease virus - classification ; Newcastle disease virus - growth &amp; development ; Newcastle disease virus - pathogenicity ; Poultry ; Poultry Diseases - immunology ; Poultry Diseases - prevention &amp; control ; Poultry Diseases - virology ; Primary Cell Culture ; Vaccination ; Vaccines ; Vaccines, Attenuated - adverse effects ; Vaccines, Attenuated - immunology ; Vaccines, Attenuated - therapeutic use ; Veterinary Microbiology ; Viral Vaccines - adverse effects ; Viral Vaccines - immunology ; Viral Vaccines - therapeutic use ; Viruses</subject><ispartof>Brazilian journal of microbiology, 2015-07, Vol.46 (3), p.861-865</ispartof><rights>Copyright Sociedade Brasileira de Microbiologia 2015</rights><rights>Copyright © 2015, Sociedade Brasileira de Microbiologia 2015</rights><rights>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-7997ed1f6944bd80dd6243f78ebe6c5b15ea0e6b723df3765854a59075a2064d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568861/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568861/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26413071$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Visnuvinayagam, Sivam</creatorcontrib><creatorcontrib>Thangavel, K</creatorcontrib><creatorcontrib>Lalitha, N</creatorcontrib><creatorcontrib>Malmarugan, S</creatorcontrib><creatorcontrib>Sukumar, Kuppannan</creatorcontrib><title>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</title><title>Brazilian journal of microbiology</title><addtitle>Braz J Microbiol</addtitle><description>Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.</description><subject>Animal diseases</subject><subject>Animals</subject><subject>Cell Culture Techniques</subject><subject>Cells, Cultured</subject><subject>Chick Embryo</subject><subject>Chickens - immunology</subject><subject>Chickens - virology</subject><subject>MICROBIOLOGY</subject><subject>Newcastle disease virus - classification</subject><subject>Newcastle disease virus - growth &amp; development</subject><subject>Newcastle disease virus - pathogenicity</subject><subject>Poultry</subject><subject>Poultry Diseases - immunology</subject><subject>Poultry Diseases - prevention &amp; control</subject><subject>Poultry Diseases - virology</subject><subject>Primary Cell Culture</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, Attenuated - adverse effects</subject><subject>Vaccines, Attenuated - immunology</subject><subject>Vaccines, Attenuated - therapeutic use</subject><subject>Veterinary Microbiology</subject><subject>Viral Vaccines - adverse effects</subject><subject>Viral Vaccines - immunology</subject><subject>Viral Vaccines - therapeutic use</subject><subject>Viruses</subject><issn>1678-4405</issn><issn>1517-8382</issn><issn>1678-4405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdUctu1DAUtRCIlsIngCKxYZNy_XY2SFUFBVHBAthiOfFNx1UmHmxnUP--HqaMBla27HPuPQ9CXlI4p7KDt9-opLo13DChOAMqACR9RE6p0qYVAuTjo_sJeZbzLQCTINhTcsKUoBw0PSU_L3LGnNc4lyaOTVlhs3FlFW9wDkMod7vHAaepHZapLAlb592moG--4O_B5TJh40NGl7HZhrTkJpfkwtx8jmuX4vY5eTK6KeOLh_OM_Pjw_vvlx_b669Wny4vrdhDalFZ3nUZPR9UJ0XsD3ism-KgN9qgG2VOJDlD1mnE_cq2kkcLVFLR0DJTw_Iyc7-fmIeAU7W1c0lwX2j8x2V1MNSMJABzAKFoJ7_aEzdKv0Q_Vf3KT3aRQdd_Z6IL992cOK3sTt1ZIZfYD3jwMSPHXgrnYdci7pNyMccmWaqqFYYbzCn39H_Qgj2pQVEvDuoqSe9SQYs4Jx4MYCnZX-ZGXo8or79WxkwPrb8f8Hm7xpXU</recordid><startdate>20150701</startdate><enddate>20150701</enddate><creator>Visnuvinayagam, Sivam</creator><creator>Thangavel, K</creator><creator>Lalitha, N</creator><creator>Malmarugan, S</creator><creator>Sukumar, Kuppannan</creator><general>Springer Nature B.V</general><general>Sociedade Brasileira de Microbiologia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>CLZPN</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>GPN</scope></search><sort><creationdate>20150701</creationdate><title>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</title><author>Visnuvinayagam, Sivam ; Thangavel, K ; Lalitha, N ; Malmarugan, S ; Sukumar, Kuppannan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-7997ed1f6944bd80dd6243f78ebe6c5b15ea0e6b723df3765854a59075a2064d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animal diseases</topic><topic>Animals</topic><topic>Cell Culture Techniques</topic><topic>Cells, Cultured</topic><topic>Chick Embryo</topic><topic>Chickens - immunology</topic><topic>Chickens - virology</topic><topic>MICROBIOLOGY</topic><topic>Newcastle disease virus - classification</topic><topic>Newcastle disease virus - growth &amp; development</topic><topic>Newcastle disease virus - pathogenicity</topic><topic>Poultry</topic><topic>Poultry Diseases - immunology</topic><topic>Poultry Diseases - prevention &amp; control</topic><topic>Poultry Diseases - virology</topic><topic>Primary Cell Culture</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, Attenuated - adverse effects</topic><topic>Vaccines, Attenuated - immunology</topic><topic>Vaccines, Attenuated - therapeutic use</topic><topic>Veterinary Microbiology</topic><topic>Viral Vaccines - adverse effects</topic><topic>Viral Vaccines - immunology</topic><topic>Viral Vaccines - therapeutic use</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Visnuvinayagam, Sivam</creatorcontrib><creatorcontrib>Thangavel, K</creatorcontrib><creatorcontrib>Lalitha, N</creatorcontrib><creatorcontrib>Malmarugan, S</creatorcontrib><creatorcontrib>Sukumar, Kuppannan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Latin America &amp; Iberia Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>SciELO</collection><jtitle>Brazilian journal of microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Visnuvinayagam, Sivam</au><au>Thangavel, K</au><au>Lalitha, N</au><au>Malmarugan, S</au><au>Sukumar, Kuppannan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov</atitle><jtitle>Brazilian journal of microbiology</jtitle><addtitle>Braz J Microbiol</addtitle><date>2015-07-01</date><risdate>2015</risdate><volume>46</volume><issue>3</issue><spage>861</spage><epage>865</epage><pages>861-865</pages><issn>1678-4405</issn><issn>1517-8382</issn><eissn>1678-4405</eissn><abstract>Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18(th)(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.</abstract><cop>Brazil</cop><pub>Springer Nature B.V</pub><pmid>26413071</pmid><doi>10.1590/S1517-838246320140051</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1678-4405
ispartof Brazilian journal of microbiology, 2015-07, Vol.46 (3), p.861-865
issn 1678-4405
1517-8382
1678-4405
language eng
recordid cdi_scielo_journals_S1517_83822015000300861
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Animal diseases
Animals
Cell Culture Techniques
Cells, Cultured
Chick Embryo
Chickens - immunology
Chickens - virology
MICROBIOLOGY
Newcastle disease virus - classification
Newcastle disease virus - growth & development
Newcastle disease virus - pathogenicity
Poultry
Poultry Diseases - immunology
Poultry Diseases - prevention & control
Poultry Diseases - virology
Primary Cell Culture
Vaccination
Vaccines
Vaccines, Attenuated - adverse effects
Vaccines, Attenuated - immunology
Vaccines, Attenuated - therapeutic use
Veterinary Microbiology
Viral Vaccines - adverse effects
Viral Vaccines - immunology
Viral Vaccines - therapeutic use
Viruses
title Assessment of the pathogenicity of cell-culture-adapted Newcastle disease virus strain Komarov
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A47%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sciel&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20the%20pathogenicity%20of%20cell-culture-adapted%20Newcastle%20disease%20virus%20strain%20Komarov&rft.jtitle=Brazilian%20journal%20of%20microbiology&rft.au=Visnuvinayagam,%20Sivam&rft.date=2015-07-01&rft.volume=46&rft.issue=3&rft.spage=861&rft.epage=865&rft.pages=861-865&rft.issn=1678-4405&rft.eissn=1678-4405&rft_id=info:doi/10.1590/S1517-838246320140051&rft_dat=%3Cproquest_sciel%3E1717482833%3C/proquest_sciel%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706175829&rft_id=info:pmid/26413071&rft_scielo_id=S1517_83822015000300861&rfr_iscdi=true